| P2093 | author name string | Daniel Bernstein | |
| | Paul Burridge | |
| P2860 | cites work | Cell-specific interaction of retinoic acid receptors with target genes in mouse embryonic fibroblasts and embryonic stem cells | Q38349181 |
| | Mechanisms and management of doxorubicin cardiotoxicity | Q38473474 |
| | The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy | Q40245145 |
| | Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience | Q41507395 |
| | Isolation and Functional Characterization of Pluripotent Stem Cell–Derived Cardiac Progenitor Cells | Q42108199 |
| | Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study | Q42957300 |
| | Naturally occurring variants of human CBR3 alter anthracycline in vitro metabolism | Q43223372 |
| | Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood | Q43253475 |
| | Chimeric analysis of retinoic acid receptor function during cardiac looping | Q44034924 |
| | Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes | Q45084863 |
| | Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21. | Q46008254 |
| | Modeling human disease with pluripotent stem cells: from genome association to function. | Q46169388 |
| | Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children. | Q46409053 |
| | Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer | Q46611556 |
| | NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity | Q46837798 |
| | Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo. | Q53618473 |
| | Doxorubicin induces senescence and impairs function of human cardiac progenitor cells. | Q54449632 |
| | Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children | Q57239656 |
| | Patterns of interaction between anthraquinone drugs and the calcium-release channel from cardiac sarcoplasmic reticulum | Q68469665 |
| | Study of the adriamycin-cardiolipin complex structure using attenuated total reflection infrared spectroscopy | Q69052077 |
| | Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy | Q73665478 |
| | Free radical involvement in doxorubicin-induced electrophysiological alterations in rat papillary muscle fibres | Q77330799 |
| | Prediction and prevention of chemotherapy-induced cardiomyopathy: can it be done? | Q79405161 |
| | Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients | Q80984345 |
| | hiPSC Modeling of Inherited Cardiomyopathies | Q28240320 |
| | Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells | Q28282675 |
| | Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3) | Q28292664 |
| | Risk factors for doxorubicin-induced congestive heart failure | Q28328220 |
| | Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood | Q28334880 |
| | Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib) | Q28511220 |
| | Genetics and beyond--the transcriptome of human monocytes and disease susceptibility | Q28752094 |
| | Patient-specific induced pluripotent stem-cell models for long-QT syndrome | Q29620353 |
| | Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome | Q30499663 |
| | Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. | Q30539904 |
| | Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity | Q33575608 |
| | Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome | Q33910479 |
| | Stepwise chemically induced cardiomyocyte specification of human embryonic stem cells | Q34108456 |
| | Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials | Q34199968 |
| | A clinicopathologic analysis of adriamycin cardiotoxicity | Q34207498 |
| | Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming | Q34245487 |
| | Identification of the molecular basis of doxorubicin-induced cardiotoxicity | Q34308627 |
| | Contribution of specific transport systems to anthracycline transport in tumor and normal cells | Q34477916 |
| | Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review. | Q34746933 |
| | Epidemiology of anthracycline cardiotoxicity in children and adults. | Q34753960 |
| | β2-adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell death pathways | Q35250102 |
| | Energy metabolism in heart failure | Q35602060 |
| | Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group. | Q36058273 |
| | Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. | Q36079527 |
| | Molecular pharmacology of the interaction of anthracyclines with iron | Q36121571 |
| | RARγ is essential for retinoic acid induced chromatin remodeling and transcriptional activation in embryonic stem cells | Q36764124 |
| | Association of anthracycline-related cardiac histological lesions with NADPH oxidase functional polymorphisms | Q36804526 |
| | Anthracycline associated cardiotoxicity in survivors of childhood cancer | Q37112428 |
| | Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia | Q37209968 |
| | Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation | Q37227651 |
| | Cardiac stem cell biology: glimpse of the past, present, and future. | Q38175372 |
| P433 | issue | 1-2 | |
| P921 | main subject | doxorubicin | Q18936 |
| | pluripotency | Q1894941 |
| | personalized medicine | Q2072214 |
| P304 | page(s) | 23-27 | |
| P577 | publication date | 2014-12-01 | |
| P1433 | published in | Progress in pediatric cardiology | Q27714610 |
| P1476 | title | Patient-Specific Pluripotent Stem Cells in Doxorubicin Cardiotoxicity: A New Window Into Personalized Medicine | |
| P478 | volume | 37 | |